Sign In
Buy CDNA
$22.31
+0.240 (+1.09%)
At Close: Jun 03, 2026
Zacks: Brokerages Expect CareDx Inc (NASDAQ:CDNA) Will Post Quarterly Sales of $35.52 Million
02:20am, Saturday, 04'th Jul 2020
Analysts expect CareDx Inc (NASDAQ:CDNA) to post $35.52 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for CareDx’s earnings. The
CareDx’s (CDNA) “Buy” Rating Reaffirmed at Piper Sandler
04:00am, Tuesday, 30'th Jun 2020
Piper Sandler reaffirmed their buy rating on shares of CareDx (NASDAQ:CDNA) in a research note issued to investors on Monday morning, TipRanks reports. The firm currently has a $54.00 target price on
Hedge Funds Aren’t Crazy About CareDx, Inc. (CDNA) Anymore
08:12pm, Wednesday, 24'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
New Kidney360 Publication Highlights CareDx’s AlloSure is Differentiated as the dd-cfDNA Test of Choice
11:00am, Monday, 22'nd Jun 2020
SOUTH SAN FRANCISCO, Calif., June 22, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
Deutsche Bank AG Boosts Stock Position in CareDx Inc (NASDAQ:CDNA)
08:39am, Sunday, 21'st Jun 2020
Deutsche Bank AG increased its holdings in CareDx Inc (NASDAQ:CDNA) by 0.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 237,795 shares of the comp
CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
08:05pm, Thursday, 18'th Jun 2020
The option was granted in connection with the public offering of 3,906,250 shares of common stock at a public offering price of $32.00 per share, which closed on June 15, 2020. After giving effect to
FDA Accepts Letter of Intent for iBox Scoring System as a Surrogate Endpoint in Pharmaceutical Clinical Trials
11:00am, Thursday, 18'th Jun 2020
SOUTH SAN FRANCISCO, Calif., June 18, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
CareDx Announces Closing of Public Offering of Common Stock
08:05pm, Monday, 15'th Jun 2020
In addition, CareDx has granted the underwriters a 30-day option to purchase up to 585,937 additional shares of its common stock. The net proceeds to CareDx from the offering are expected to be appro
CareDx Announces Pricing of Public Offering of Common Stock
01:12am, Thursday, 11'th Jun 2020
SOUTH SAN FRANCISCO, Jun 10, 2020 (GLOBE NEWSWIRE via COMTEX) --
SOUTH SAN FRANCISCO, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA),...
CareDx Announces Pricing of Public Offering of Common Stock
12:12am, Thursday, 11'th Jun 2020
The gross proceeds to CareDx from this offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $125,000,000. In addition, CareDx has granted the un
The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset
11:30am, Wednesday, 10'th Jun 2020CareDx Announces Proposed Public Offering of Common Stock
09:13pm, Tuesday, 09'th Jun 2020
CareDx also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional $15.0 million of shares of its common stock offered in the public offering on the same ter
Seven Bridges Selected by CareDx to Advance Its Transplant Care Solutions
12:00pm, Tuesday, 09'th Jun 2020
Seven Bridges, the industry-leading bioinformatics ecosystem provider, announced today a new partnership with CareDx, Inc. (Nasdaq: CDNA) supporting the CareDx AlloSure 3.0 workflow. CareDx is a leadi
CareDx Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting
09:00pm, Monday, 08'th Jun 2020
Due to conditions associated with the impact of the Coronavirus pandemic (COVID-19), including restrictions on in-person gatherings, and in order to support the health and well-being of our stockholde
